The essential trace minerals, immunity, and progression of HIV-1 infection

被引:20
作者
Bogden, John D. [1 ]
Oleske, James M.
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Prevent Med & Community Hlth, Newark, NJ 07103 USA
[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pediat, Newark, NJ 07103 USA
关键词
AIDS; copper; HIV-1; immunity; iron; progression; selenium; trace minerals; zinc;
D O I
10.1016/j.nutres.2007.01.002
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Studies of the effects of the essential trace minerals on immunity can provide insight into the role of trace element nutrition in HIV-1 infection and its progression to AIDS. Of the 9 essential trace elements, only 4 have been studied in patients with HIV-1 infection. These are copper, iron, selenium, and zinc. Serum copper concentrations are increased considerably in a wide variety of infections, including HIV-1, but there is no evidence of deficiency during infection. HIV infection eventually results in development of the anemia of chronic infection, with low serum iron and transferrin levels and increased serum ferritin. There is considerable evidence for selenium deficiency in HIV-1-infected subjects from various countries that is associated with more rapid disease progression and increased mortality. Declining serum zinc with progression is both a nonspecific marker of infection and evidence of zinc deficiency. Increases in the serum copper/zinc ratio and ferritin and decreases in serum selenium are markers of HIV-1 progression. Paradoxically, supplementation with iron or zinc may increase the rate of progression and supplemental selenium has been associated with increased vaginal shedding of the HIV-1 virus and thus may increase the risk of heterosexual female-to-male transmission. Supplementation of HIV-1-infected patients with Dietary Reference Intake levels of the above essential trace minerals is prudent, but high doses should be discouraged. The combination of antiretroviral drug therapy, a healthy diet, and a low-dose multivitamin/mineral supplement may be especially effective in the treatment of HIV-1-infected patients. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:69 / 77
页数:9
相关论文
共 47 条
  • [1] Baeten JM, 2001, J ACQ IMMUN DEF SYND, V26, P360, DOI 10.1097/00126334-200104010-00013
  • [2] Zinc status in human immunodeficiency virus type 1 infection and illicit drug use
    Baum, MK
    Campa, A
    Lai, SG
    Lai, H
    Page, JB
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 : S117 - S123
  • [3] High risk of HIV-related mortality is associated with selenium deficiency
    Baum, MK
    ShorPosner, G
    Lai, SH
    Zhang, GY
    Fletcher, MA
    Sauberlich, H
    Page, JB
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1997, 15 (05) : 370 - 374
  • [4] Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans
    Beck, FWJ
    Prasad, AS
    Kaplan, J
    Fitzgerald, JT
    Brewer, GJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 272 (06): : E1002 - E1007
  • [5] Selenium deficiency increases the pathology of an influenza virus infection
    Beck, MA
    Nelson, HK
    Shi, Q
    Van Dael, P
    Schiffrin, EJ
    Blum, S
    Barclay, D
    Levander, OA
    [J]. FASEB JOURNAL, 2001, 15 (06) : 1481 - +
  • [6] Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: Pooled analysis of randomized controlled trials
    Bhutta, ZA
    Black, RE
    Brown, KH
    Gardner, JM
    Gore, S
    Hidayat, A
    Khatun, F
    Martorell, R
    Ninh, NX
    Penny, ME
    Rosado, JL
    Roy, SK
    Ruel, M
    Sazawal, S
    Shankar, A
    [J]. JOURNAL OF PEDIATRICS, 1999, 135 (06) : 689 - 697
  • [7] Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial
    Bobat, R
    Coovadia, H
    Stephen, C
    Naidoo, KL
    McKerrow, N
    Black, RE
    Moss, W
    [J]. LANCET, 2005, 366 (9500) : 1862 - 1867
  • [8] Bogden J D, 2004, J Nutr Health Aging, V8, P48
  • [9] BOGDEN JD, 1978, HEALTH LAB SCI, V15, P38
  • [10] Bogden JD, 2000, NUTR HLTH, P3